Global Lab Automation in Protein Engineering Market to Thrive at a 7.2% CAGR, Projected to Reach $1.8 Billion by 2030
MarkWide Research proudly presents its latest report, “Global Lab Automation in Protein Engineering Market,” offering comprehensive insights into the dynamic field of lab automation in protein engineering. With an anticipated compound annual growth rate (CAGR) of 7.2% from 2023 to 2030, the global lab automation in protein engineering market is on track to achieve a substantial valuation of $1.8 billion by the conclusion of the forecast period.
Revolutionizing Protein Engineering
Lab automation has revolutionized protein engineering by streamlining workflows, increasing throughput, and enabling high-throughput screening of protein variants. As biotechnology and pharmaceutical industries focus on developing novel biologics and therapeutics, the demand for lab automation in protein engineering is rapidly increasing.
Accelerating Drug Discovery
Lab automation expedites drug discovery processes by enabling the rapid generation and analysis of protein variants. This technology is instrumental in developing biotherapeutics, enzymes, and vaccines, contributing to the advancement of healthcare.
Customized Solutions
Lab automation systems are highly customizable to meet the specific needs of protein engineering projects. They can handle tasks such as cloning, expression, purification, and characterization, providing researchers with precise control and efficiency.
Global Adoption
The lab automation in protein engineering market has a global footprint, with North America, Europe, and Asia-Pacific as major regions of adoption. Asia-Pacific, in particular, is witnessing significant growth due to the expansion of biopharmaceutical research and development.
Key Market Players
Prominent companies in the global lab automation in protein engineering market include PerkinElmer Inc., Thermo Fisher Scientific Inc., Agilent Technologies, Inc., Bruker Corporation, and Beckman Coulter, Inc. These industry leaders continually innovate to provide cutting-edge lab automation solutions that meet the evolving needs of protein engineers.
Market Projections
MarkWide Research’s report projects that the global lab automation in protein engineering market will attain a valuation of $1.8 billion by 2030, with a robust CAGR of 7.2%. As the demand for biologics and personalized medicine grows, lab automation will play a pivotal role in advancing protein engineering capabilities.
Conclusion
The global lab automation in protein engineering market is poised for substantial growth as biotechnology and pharmaceutical industries seek to accelerate research and development efforts. Lab automation not only enhances efficiency but also empowers researchers to make breakthroughs in drug discovery and protein design.
For comprehensive insights and detailed market analysis, refer to MarkWide Research’s full report on the lab automation in protein engineering market. Embrace the future of protein engineering by leveraging lab automation to advance your research and development initiatives.